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Abstract: Influenza-like illnesses (ILI) account for a significant portion of inappropriate antibiotic use.
Patient expectations for antibiotics for ILI are likely to play a substantial role in ‘unnecessary’ antibiotic
consumption. This study aimed to investigate trends in awareness of appropriate antibiotic use
and antimicrobial resistance (AMR). Three sequential online surveys of independent representative
samples of adults in the United Kingdom investigated expectations for, and consumption of, antibiotics
for ILI (May/June 2015 (n = 2064); Oct/Nov 2016 (n = 4000); Mar 2017 (n = 4000)). Respondents
were asked whether they thought antibiotics were effective for ILI and about their antibiotic use.
Proportions and 95% confidence intervals (CI) were calculated for each question and interactions
with respondent characteristics were tested using logistic regression. Over the three surveys, the
proportion of respondents who believed antibiotics would “definitely/probably” help an ILI fell from
37% (95% CI 35–39%) to 28% (95% CI 26–29%). Those who would “definitely/probably” visit a doctor
in this situation fell from 48% (95% CI 46–50%) to 36% (95% CI 34–37%), while those who would
request antibiotics during a consultation fell from 39% (95% CI 37–41%) to 30% (95% CI 29–32%).
The percentage of respondents who found the information we provided about AMR “new/surprising”
fell from 34% (95% CI 32–36%) to 28% (95% CI 26–31%). Awareness improved more among black,
Asian and minority ethnic (BAME) than white people, with little other evidence of differences in
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improvements between subgroups. Whilst a degree of selection bias is unavoidable in online survey
samples, the results suggest that awareness of AMR and appropriate antibiotic use has recently
significantly improved in the United Kingdom, according to a wide range of indicators.
Keywords: antibiotics; antimicrobial resistance; survey
1. Introduction
Antibiotic use is a key driver of antibiotic resistance [1,2]. In England, around 80% of antibiotics
are prescribed in primary care [3]. For most conditions, only a minority of antibiotic prescriptions given
are necessary [4]. Moreover, a large part of the variation in prescribing rates between general practices
cannot be explained by differences in patient comorbidities or other factors such as smoking [5–7].
Almost half of all antibiotics prescribed in primary care are for respiratory tract infections (RTIs) such
as influenza-like illnesses (ILI), which do not generally require antibiotics [8]. General practitioners
(GPs) are more likely to prescribe antibiotics when patients request them or are perceived to want
them [9,10]. Thus, while there are many reasons why GPs might prescribe unnecessary antibiotics
for ILI [11], patients’ attitudes towards antibiotics and AMR, and patient consultations and antibiotic
requests for ILI may play an important role.
Prior to the timeframe for our study (May 2015–March 2017), a large proportion of the United
Kingdom (UK) population believed that antibiotics were effective for ILI, about one third saying they
would expect their GP to prescribe antibiotics [12]. Using three sequential online surveys, originally
designed to evaluate what drives such beliefs and how different fear-based messages could modify
such beliefs [13,14], we assess here potential changes over time in a range of indicators of awareness of
AMR and appropriate antibiotic use in the overall population and in subgroups.
2. Methods
2.1. Survey Design
Three web-based surveys were conducted in which members of the general public were asked
questions about antibiotics and AMR [13,14]. The surveys are described in detail elsewhere [13,14].
The 1st survey [13], conducted in May–June 2015, was primarily designed to investigate what
drives patient expectations for antibiotics for ILI; particularly whether AMR-awareness, risk preference
or time preference play a role. The 2nd and 3rd surveys [14], conducted during Oct–Nov 2016 and
March 2017, respectively, were primarily designed to develop and test the impact of providing different
types of information about antibiotic use and AMR on consultations and requests for antibiotics for ILI.
Here we focused on 9 key questions and corresponding variables that were common to all 3
surveys and thus permitted analyses of trends over time in awareness of AMR and attitudes towards
the use of antibiotics for ILIs.
The surveys (see supplementary materials) asked respondents to imagine Health State A.
This health state was intended to describe symptoms of ILI, for which antibiotics are generally not
necessary [4], but for which many members of the general public believe antibiotics are effective [12].
2.2. Health State A: You Have
• A temperature,
• Aching muscles,
• A headache,
• A dry chesty cough,
• A sore throat,
• And you feel weak
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Health state A was described symptomatically because individuals are likely to interpret terms
like “flu” or “virus” differently. Moreover, some respondents may know that antibiotics are not
required for viral conditions but not realise that these symptoms are more consistent with a viral
infection. Respondents were asked how they would respond in the hypothetical situation of having
experienced Health State A for 5 days. They were asked whether they thought they would go to see a
GP about these symptoms. Except for those who said, ‘Definitely not’, respondents were then asked
whether if they did see a GP, they thought they would ask for antibiotics. Respondents were also asked
whether they thought antibiotics would be likely to help these symptoms and whether they had taken
antibiotics for similar symptoms in the last 12 months. Participants with dependent children then
answered analogous questions regarding their youngest child being ill with ILI symptoms, consulting
a GP and requesting antibiotics.
To assess AMR-awareness, respondents were given the information in Box 1, which paraphrased
text on the websites of 4 institutions with initiatives aiming to improve AMR-awareness [15–18].
The message was the same across surveys, though the wording was simplified slightly after Survey 1 to
improve readability and comprehension (Box 1). Participants were asked how “surprising” (Survey 1)
or “new” (Surveys 2 and 3) they found the information.
Together, the questions provided 9 indicators of awareness of AMR and attitudes towards antibiotic
use for ILI (Box 2). The surveys also captured information on other factors that might be associated
with awareness of AMR and antibiotic use (Table 1).
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Box 1. Information about antimicrobial resistance (AMR) given to survey respondents.
Information wording in Survey 1
“Antibiotic resistance occurs when an antibiotic loses its ability to effectively control or kill growing bacteria. It is an increasingly serious threat to public health. Without effective
antibiotics, many routine treatments will become increasingly dangerous. Setting broken bones, and even basic operations, rely on access to antibiotics that work. Antibiotic resistance is believed
to be caused by unnecessary use of antibiotics, and inappropriate use, such as not taking them as prescribed, skipping doses, or saving them for later use.”
Information wording in Surveys 2 and 3
“Antibiotic resistance happens when an antibiotic no longer kills or controls growing bacteria. It is an increasingly serious threat to public health. Without antibiotics that work well,
many routine treatments will become increasingly dangerous. Setting broken bones, and even basic operations, rely on access to antibiotics that work. Antibiotic resistance is believed to be
caused by unnecessary use of antibiotics, and inappropriate use, such as not taking them as prescribed, skipping doses, or saving them for later use.”
NOTE: The wording in Surveys 2 and 3 was intended to have exactly the same meaning as that in Survey 1. Minor changes in wording were made to the
first and third sentences to make them easier to read and understand.
Box 2. Nine indicators of awareness of AMR and attitudes to the use of antibiotics for ILI.
All Respondents
“At this point [5 days of ILI symptoms], do you think you would go to see a GP about these symptoms?” [Definitely/Probably/Probably not/Definitely not/Don’t know]
“If you went to see a GP about these symptoms, do you think you would ask for antibiotics?” [Definitely/Probably/Probably not/Definitely not/Don’t know]
“Do you think antibiotics would be likely to help these symptoms?”
[Definitely/Probably/Probably not/Definitely not/Don’t know]
“To the best of your knowledge, have you taken antibiotics for symptoms similar to these in the last 12 months?” [Yes/No]
“To what extent is this information [Text in Box 1] new (surprising) to you?” [Very (surprising) new/Somewhat (surprising) new/Not very (surprising) new/Not at all (surprising) new]
Respondents With Children Only
“At this point [5 days of ILI symptoms], do you think you would take your child to see a GP about these symptoms?” [Definitely/Probably/Probably not/Definitely not/Don’t know]
“If you did take your child to see a GP about these symptoms, do you think you would ask for antibiotics?” [Definitely/Probably/Probably not/Definitely not/Don’t know]
“Do you think antibiotics would be likely to help your child in this situation?” [Definitely/Probably/Probably not/Definitely not/Don’t know]
“To the best of your knowledge, has your child taken antibiotics for symptoms similar to these in the last 12 months?” [Yes/No]
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Table 1. Respondent characteristics.
Survey 1
(May–June 2015)
(n = 2064) a
Survey 2
(Oct–Nov 2016)
(n = 4000) a
Survey 3
(Mar 2017)
(n = 4000) a
Gender
Male 994 (48.2%) 1941 (48.5%) 1941 (48.5%)
Female 1067 (51.7%) 2055 (51.4%) 2055 (51.4%)
Missing 3 (0.1%) 4 (0.1%) 4 (0.1%)
Age (years)
Mean (SD) 44.2 (15.7) 46.6 (16.9) 46.5 (16.8)
Ethnicity
White 1821 (88.2%) 3624 (90.6%) 3606 (90.2%)
Black, and minority ethnic (BAME) 221 (10.7%) 352 (8.8%) 372 (9.3%)
Missing 22 (1.1%) 24 (0.6%) 22 (0.6%)
Religion
Christian 1019 (49.4%) 1986 (49.6%) 1858 (46.5%)
No or other religion 988 (47.9%) 1913 (47.8%) 2049 (51.2%)
Missing 57 (2.8%) 101 (2.5%) 93 (2.3%)
Married/civil partnership/live with a partner
Yes 1351 (65.5%) 2720 (68.0%) 2668 (66.7%)
No 713 (34.5%) 1280 (32.0%) 1332 (33.3%)
Have dependent children
Yes 816 (39.5%) 1600 (40%) 1600 (40%)
No 1248 (60.5%) 2400 (60%) 2400 (60%)
Higher education
Attained higher education 954 (46.2%) 1875 (46.9%) 1756 (43.9%)
Did not attain higher education 1093 (53.0%) 2125 (53.1%) 2244 (56.1%)
Missing 17 (0.8%) 0 (0%) 0 (0%)
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Table 1. Cont.
Survey 1
(May–June 2015)
(n = 2064) a
Survey 2
(Oct–Nov 2016)
(n = 4000) a
Survey 3
(Mar 2017)
(n = 4000) a
Unemployed
Yes 105 (5.1%) 202 (5.0%) 184 (4.6%)
No 1959 (94.9%) 3798 (95.0%) 3816 (95.4%)
Household equivalent income £
Mean (SD) 22,405 (18,343) 22,109 (17,123) 20,477 (15,012)
Missing 186 (9.0%) 390 (9.8%) 357 (8.9%)
Region
England 1780 (86.2%) 3381 (84.5%) 8542 (84.9%)
Northern Ireland 32 (1.6%) 104 (2.6%) 240 (2.4%)
Scotland 161 (7.8%) 318 (8.0%) 797 (7.9%)
Wales 91 (4.4%) 197 (4.9%) 485 (4.8%)
Antibiotic use
Taken antibiotics for any condition in last 12 months 815 (39%) 1367 (34%) 1422 (36%)
NOTE: a. Survey Sampling International was commissioned to provide at least 2000 completed responses in Survey 1 [13]. The larger sample sizes of 4000 were commissioned in Surveys 2
and 3 to support a randomized experiment with three arms [14].
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2.3. Survey Participants
The surveys were conducted online using panels of respondents provided by Survey Sampling
International (SSI). For the first survey, SSI was commissioned to obtain a sample of at least 2000
completed responses, representative of adult members of the general public in terms of gender, age,
ethnicity and geographic region. For the second and third surveys, SSI was commissioned to obtain
samples of 4000 completed responses, again representative of the UK-resident adult members of the
general public (the larger sample sizes needed to support a randomized experiment with three arms
reported elsewhere [14]). In total, 6280; 28,887; and 8317 SSI panel members were invited via email for
the first, second and third survey, respectively. It was also possible for SSI panel-members to access
the surveys via SSI’s website. Respondents were only allowed to participate in one survey, thereby
preventing potential learning from previous surveys.
Respondents were offered a small incentive to complete the surveys in the form of ‘Nectar points’
(a loyalty-card scheme via which customers accrue discounts at outlets including supermarkets and
restaurants), worth a total of approximately £0·60.
2.4. Statistical Analysis
Chi-squared tests were used to test whether the 9 indicators of AMR-awareness and attitudes
towards antibiotics were the same in Survey 1 (May–June 2015) and Survey 3 (March 2017). Indicators
were also reported for Survey 2 (Oct–Nov 2016) for full disclosure, but we did not test for differences
between Surveys 1 and 2 or Surveys 2 and 3. This was because attitudes may be different before
(Survey 2) and after (Surveys 1 and 3) the seasonal peak in ILI incidence [19]. Confidence intervals
were estimated using Wilson score intervals.
To explore whether awareness/attitudes improved more/less in certain subgroups, we used logistic
regression models that allowed for interaction terms between time and respondent characteristics.
Because the surveys were not equally spaced in time, and, as above, because attitudes may be different
before and after the seasonal peak in ILI incidence [19], we only included data from Surveys 1 and 3 in
this analysis and simplified ‘time’ to a dummy variable. The following variables were included as main
effects in each model: Gender, age, age of child (for child-related questions), household income, being
unemployed, white ethnicity, having completed higher education and having been born in the United
Kingdom. Interactions between each variable and time (Survey 1 vs. 3) were introduced separately
to each model, only one interaction included each time. We performed complete case analyses as
variables like household income are unlikely to be reliably imputed using data from available variables.
Moreover, complete case analysis is valid when missingness in a covariate is independent of the
outcome conditional on the regression model’s covariates [20,21]. The estimated marginal effects and
p-values of the interaction terms were plotted for each regression model. All statistical analyses were
done using R version 3.5.1.
3. Results
Survey 1 was completed by 2064 respondents. Surveys 2 and 3 were each completed by 4000
respondents (Table 1).
3.1. Shifts in Attitudes over Time
Awareness of AMR and appropriate antibiotic use improved over time (Table 2). While 48% of
respondents said that they would go to the GP if they experienced 5 days of ILI symptoms in Survey
1 (May–June 2015), only 36% of respondents indicated they would do so in Survey 3 (March 2017).
In Survey 1, 39% of respondents indicated that if they did see a GP for ILI symptoms, they would ask
the GP for antibiotics. By Survey 3, this percentage had decreased to 30%. There was a substantial
overlap between those respondents who would go to the GP for ILI symptoms and those who would
ask for antibiotics. In Survey 1, of the 706 respondents who indicated that they would ask for antibiotics
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if they went to see a GP for ILI symptoms, 561 (79%) said that they would indeed be likely to see a GP
in this situation. In Survey 3, of the 975 respondents who indicated that they would ask for antibiotics
if they went to see a GP, 736 (75%) said that they would be likely to see a GP in this situation.
In total, 37% of respondents from Survey 1 thought that antibiotics would help if they experienced
ILI, and 53% thought antibiotics would be effective for their child with ILI. By Survey 3, these figures
had decreased to 28% and 43%, respectively. The percentage of respondents who indicated that the
AMR information (Box 1) was new/surprising declined from 34% in Survey 1 to 28% in Survey 3.
The percentage of respondents who had used antibiotics for ILI in the 12 months before the survey
also declined over time, from 21% in Survey 1 to 14% in Survey 3. Although past antibiotic use for ILI
was higher in children across the surveys, a similar decline in use was observed between Surveys 1
and 3 from 25% to 20%.
3.2. Shifts in Awareness among Subgroups
For most indicators, there was little evidence of subgroups for which awareness improved less
than for others (Figure 1 and Supplementary Figures S1–S8). The only factor for which there was
evidence (p < 0.05 for interaction with time) for multiple indicators that improvement in awareness
differed by subgroup was ethnicity. Awareness improved more among BAMEs than whites for the
following three indicators: (1) Going to GP with child with ILI, (2) asking for antibiotics when going
to GP with ILI, and (3) finding the AMR information that was provided new/surprising. Effectively,
awareness among BAMEs and whites became more similar over time for these indicators.
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Table 2. Shifts in attitudes across the three surveys.
Survey 1
(May–June 2015)
n = 2064
n (%; 95% CI)
Survey 2
(Oct–Nov 2016)
n = 4000
n (%; 95% CI)
Survey 3
(March 2017)
n = 4000
n (%; 95% CI)
p-Value d
Definitely/Probably go to GP for ILI 988 (48%; 46–50%) 1587 (40%; 38—41%) 1438 (36%; 34–37%) <0.0001
Would ask GP for antibiotics if went 706/1816 a (39%; 37–41%) 1084/3298 a (33%; 31–24%) 975/3236 a (30%; 29–32%) <0.0001
Think antibiotics would definitely/probably help ILI 762 (37%; 35–39%) 1,153 (29%; 27–30%) 1,112 (28%; 26–29%) <0.0001
Have taken antibiotics for ILI in last 12 months 426 (21%; 19–22%) 595 (15%; 14–16%) 580 (14%; 13–16%) <0.0001
Definitely/Probably go to GP for child with ILI 673/816 b (82%, 80–85%) 1232/1600 b (77%; 75–79%) 1191/1600 b (74%; 72–77%) <0.0001
Would ask GP for antibiotics for child with ILI if went 419/797 c (53%; 49–56%) 734/1519 c (48%; 46–51%) 671/1526 c (44%; 41–46%) <0.0001
Think antibiotics would definitely/probably help child with ILI 430/816 b (53%; 49–56%) 740/1600 b (46%; 44–49%) 688/1600 b (43%; 41–45%) <0.0001
Child has taken antibiotics for ILI in last 12 months 200/816 (25%; 22–28%) 338/1600 (21%; 19–23%) 319/1600 (20%; 18–22%) 0.0097
AMR information (Box 1) is very/somewhat new (very/somewhat
surprising in Survey 1) 705 (34%; 32–36%) 303/1000 (30%; 28–33%) 285/1000 (28%; 26–31%) 0.0017
NOTES: a. Denominator here is all respondents except those who said they would ‘definitely not’ go to GP for ILI; b. The denominator here is number of respondents with dependent
children; c. The denominator here is all respondents except those who said they would ‘definitely not’ go to GP for child with ILI; d. p-values compare Survey 1 with Survey 3.
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4. Discussion
4.1. Summary
The findings from these surveys suggest that awareness of AMR and appropriate antibiotic use
have improved over time. In the most recent survey, respondents were substantially more likely to be
aware of AMR and appropriate antibiotic use. Moreover, the number of adults, and their children,
who had taken antibiotics for ILI in the previous 12 months declined.
Just as diseases often cluster within certain populations according to sociodemographic factors [22],
so too does antibiotic use. There is evidence in England and Wales of significant variation in
antibiotic prescribing levels by area-level deprivation, with higher prescribing levels in more deprived
areas [7,23,24]. Moreover, this association is not fully explained by differences in the prevalence of
common chronic conditions or smoking status [7,24]. In previous work using the present dataset,
several of the indicators used in this study have been shown to be associated with a number of
sociodemographic characteristics [13]. In multivariable regression analyses, there were generally
strong independent associations with gender and ethnicity and some evidence of independent
associations with age and self-reported health status [13]. Interestingly, after adjusting for other
characteristics, there was only limited evidence of independent association with household income [13].
Encouragingly, in this study, we found generally little evidence that the observed trends in
improving awareness were restricted to or were weaker in any particular population subgroups.
The exception was ethnicity, where some AMR and appropriate antibiotic use awareness indicators
improved more among BAMEs. However, this is also encouraging as the indicators in Survey 1
suggest that awareness of AMR and appropriate antibiotic use was initially poorer among BAMEs than
whites [13]. Nevertheless, despite the observed improvements, in the most recent survey, a substantial
proportion of respondents still said that the information we gave to them in the survey about AMR
was new to them and that antibiotics would be likely to help ILI symptoms.
4.2. Strengths and Limitations
A key limitation of this study is that only members of the online survey panels participated.
A degree of selection bias is unavoidable in online survey samples as persons with no interest in
completing surveys, no internet-access or no basic computer literacy cannot be included. Nevertheless,
the panels were broadly representative of the general UK population in terms of age, gender, ethnicity,
region and unemployment, though, as is common in online surveys, the percentage with higher
education was relatively high [13].
Respondents’ answers may not reflect what they will actually do in practice. However, it
seems likely that the observed changes in expectations and attitudes are likely to support desirable
consultation behaviour in future.
The surveys were not explicitly designed to investigate changes in attitudes over time and there
was limited scope to include further questions that might have helped with interpreting the results.
For example, additional questions might have sought to ascertain awareness of media campaigns or
news about AMR around the time the surveys were in the field. The three surveys were conducted
during a period in which the need to tackle AMR was gaining increasing prominence in the UK. In
particular, the Review on Antimicrobial Resistance, commissioned by the UK government in July 2014,
produced an initial report [25] in December 2014 and its final report and recommendations [26] in
the summer of 2016. Stark warnings from this review, including estimates that AMR could result
in up to 10 million deaths by 2050, generated considerable media attention. Other notable public
events included European Antibiotic Awareness Day, which occurs annually on 18th November, and
the ongoing Antibiotic Guardian Campaign [16], which launched in September 2014 and invites
people to make a pledge related to what they personally will do to help to conserve antibiotics. There
is evidence that the Antibiotic Guardian Campaign has been an effective tool for engaging people
with the problem of AMR, increasing self-reported knowledge and changing behaviour, especially
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among those with prior awareness of the topic [27]. There were also other interventions such as
the Treat Antibiotics Responsibly, Guidance, Education, Tools (TARGET) toolkit [28,29], which was
designed to help influence prescribers’ and patients’ personal attitudes, social norms and perceived
barriers to optimal antibiotic prescribing [30]. A pragmatic randomised controlled trial found that
interactive workshops, delivered as part of the TARGET intervention, helped to reduce antibiotic
dispensing [31]. However, the three surveys from the current study cannot be used to disentangle
to what extent improvements in awareness of AMR and appropriate use of antibiotics were driven
by public campaigns or interventions such as these. The potential relative and incremental benefit
of public campaigns and other interventions, including their possibly differing impacts in different
population subgroups, would ideally be assessed via randomised designs [14,32].
The three surveys differed with respect to their timing in relation to the seasonal peak in ILI
incidence. Moreover, the severity of the influenza seasons during the study period also varied [33].
Attitudes may have been influenced by the proximity to and the severity of these seasons. However, it
is not feasible to disentangle these possible effects using these data.
The setting for this study was the UK, and a further limitation is that trends in awareness
of appropriate antibiotic use are likely to vary across countries. For example, a meta-analysis
of cross-sectional studies published during 2000 to 2013, stratified by continents, found that an
inappropriate answer to the statement “Antibiotics are useful for cold and flu,” was given by 69.0% of
respondents in Oceania but only 28.0% in Europe [34].
4.3. Comparison with Existing Literature
During the study period, antibiotic prescribing in primary care in England declined by
approximately 8% between the respective second quarters of 2015 and 2017 [35]. This decline
is likely largely due to a reduction in antibiotic use for RTIs, such as ILI, that generally do not require
antibiotics [4,5]. Our results suggest that the reduction in prescriptions may not only be a consequence
of behaviour change among GPs but may also be partly due to simultaneous changes in the attitudes
and awareness of patients.
While changes in attitudes may lead to fewer antibiotics being prescribed, reducing antibiotic
prescribing has also been shown to reduce GP consultation rates for both upper and lower RTIs [36,37].
This is particularly relevant given that consultation rates explain a large part of the variation in
antibiotic prescribing [6]. It is, therefore, encouraging that we not only found that patients were less
likely to ask for antibiotics for ILI, but also less likely to consult, in the most recent survey.
Public perceptions of AMR and appropriate use of antibiotics in primary care have been surveyed
in previous studies [12,38–40]. Our descriptive results broadly concur with previous studies in
confirming wide-ranging misunderstanding about how effective antibiotics are for ILI, and lack
of awareness of AMR. 48% of our respondents from Survey 1 (May–June 2015) said they would
‘definitely/probably’ consult a GP if they had an ILI for five days. By comparison, McNulty et al. [12]
found that in 2011 only 20% of respondents who had RTI symptoms in the last six months reported
contacting or visiting a doctor. However, their question was much broader, including all those who
had experienced not only ILI but also sore throat, cold or cough. Our Survey 1 finding, that 39% of
respondents would ask a GP for antibiotics for ILI, while 37% believed antibiotics would help, were
also broadly consistent with McNulty et al. [12], who reported that 38% of their sample believed
antibiotics could kill viruses, while 32% would expect their GP to prescribe antibiotics for ILI. In Survey
1, 21% (39%) of respondents reported having taken antibiotics for ILI (all conditions) in the last 12
months. A study using The Health Improvement Network (THIN) UK primary care database found
that approximately 30% of patients were prescribed at least one antibiotic per year for all conditions
during 2011–2013 [41]. Therefore, respondents to our survey may have been prescribed antibiotics
more frequently than the general UK public. While this may mean that our results are not necessarily
generalizable to individuals who use less antibiotics, one could argue that in the case of ILI this is
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not an important limitation, as improvements are most needed among those who take antibiotics for
conditions that generally do not require them.
4.4. Implications for Future Research and Clinical Practice
Although we found an improvement in awareness of AMR and appropriate antibiotic use, there
remains a substantial proportion of the UK general population who think that antibiotics would help
ILI symptoms, and who would ask their GP for antibiotics in a consultation. There is an urgent need
for further research that evaluates how such beliefs might be successfully challenged, for example,
in public health campaigns. One promising avenue shown to have the potential for improving the
indicators in our surveys is to provide people with fear-based messages about AMR together with
empowering information on how to effectively self-manage symptoms without antibiotics [14].
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